Anticancer composition comprising obovatol or obovatal
- 专利权人:
- Byoung-Mog Kwon
- 发明人:
- Byoung-Mog Kwon,Kwang-Hee Son,Dong-Cho Han,Su-Kyung Lee,Jung-Min Kim,Young-Hee Kho,Hyo-Kon Chun,Jae-Young Yang
- 申请号：
- US12194230
- 公开号：
- US08367736B2
- 申请日:
- 2008.08.19
- 申请国别(地区):
- US
- 年份:
- 2013
- 代理人:
- 摘要：
- Disclosed herein is an anticancer composition, comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof. The composition exhibits the activity of inhibiting the growth of cancer cells and suppressing the expression and activity of matrix metalloproteinases (MMPs), and thus can be useful for the prophylaxis and treatment of cancer as well as for the inhibition of cancer metastasis.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ELK3 ELK3 Method for screening agent for treatment of cancers or inhibition of cancer metastasis using ELK3 and pharmaceutical composition for the treatment of cancers or inhibition of cancer metastasis containing the inhibitors of ELK3 expression or activity
- Pharmaceutical composition for the treatment of cancers or inhibition of cancer metastasis containing the inhibitors of Gpr171 expression or activity
- Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient
- A composition for cancer treatment or metastasis suppression comprising an expression inhibitor or activity inhibitor of p34 as an active ingredient
- Pharmaceutical composition for the treatment of cancers or inhibition of metastasis containing the expression or activity inhibitors of MAP7D2, a novel cancer therapeutic target
